New hope for tough lung cancers: trial tests Next-Gen drugs

NCT ID NCT04938817

Recruiting now Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing several new experimental drugs, alone or combined with an existing immunotherapy (pembrolizumab), for people with an aggressive form of lung cancer. It is for patients whose cancer has continued to grow despite their first treatment, which included a similar type of immunotherapy. The main goals are to find safe doses and see if these new treatments can shrink tumors or slow the cancer's progression.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asan Medical Center-Lung Cancer Center ( Site 4103)
COMPLETED

Seoul, 05505, South Korea
Banner MD Anderson Cancer Center ( Site 0152)
COMPLETED

Gilbert, Arizona, 85234, United States
Baptist Health Lexington-Research ( Site 0158)
COMPLETED

Lexington, Kentucky, 40503, United States
Cantonal Hospital St.Gallen-Oncology & Hematology ( Site 3502)
ACTIVE_NOT_RECRUITING

Sankt Gallen, Canton of St. Gallen, 9000, Switzerland
Chungbuk National University Hospital ( Site 4106)
RECRUITING

Cheongju-si, North Chungcheong, 28644, South Korea

Contact Phone: •••-•••-••••
Cleveland Clinic-Taussig Cancer Center ( Site 0166)
COMPLETED

Cleveland, Ohio, 44195, United States
Cross Cancer Institute ( Site 3004)
COMPLETED

Edmonton, Alberta, T6G 1Z2, Canada
GBUZ "SPb CRPCstmc(o)" ( Site 3705)
COMPLETED

Saint Petersburg, Sankt-Peterburg, 197758, Russia
GBUZ LOKB-Oncology department #1 ( Site 3701)
COMPLETED

Saint Petersburg, Sankt-Peterburg, 194291, Russia
Hollywood Private Hospital-Medical Oncology ( Site 4001)
RECRUITING

Perth, Western Australia, 6009, Australia

Contact Phone: •••-•••-••••
Hospital Clinic de Barcelona ( Site 3404)
RECRUITING

Barcelona, 08036, Spain

Contact Phone: •••-•••-••••
Hospital Universitari Vall d'Hebron-Oncology ( Site 3401)
RECRUITING

Barcelona, 08035, Spain

Contact Phone: •••-•••-••••
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 3301)
RECRUITING

Rozzano, Milano, 20089, Italy

Contact Phone: •••-•••-••••
Instituto Catalan de Oncologia - Hospital Duran i Reynals ( Site 3403)
RECRUITING

L'Hospitalet de Llobregat, Catalonia, 08908, Spain

Contact Phone: •••-•••-••••
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 3304)
RECRUITING

Milan, 20141, Italy

Contact Phone: •••-•••-••••
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 3800)
COMPLETED

Szolnok, Jász-Nagykun-Szolnok, 5004, Hungary
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 3100)
RECRUITING

Vienna, 1210, Austria

Contact Phone: •••-•••-••••
Krasnoyarsk Regional Oncology Dispensary, Named after Krizhanovsky ( Site 3708)
COMPLETED

Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia
MFSMC-HJWCI-Oncology Research ( Site 0178)
COMPLETED

Baltimore, Maryland, 21237, United States
Meir Medical Center. ( Site 3601)
RECRUITING

Kfar Saba, 4428164, Israel

Contact Phone: •••-•••-••••
Monash Health-Oncology Research ( Site 4005)
COMPLETED

Clayton, Victoria, 3168, Australia
N.N.Petrov Research Institute of Oncology-Department of Chemotherapy and Innovative Technologies ( Site 3703)
COMPLETED

Saint Petersburg, Sankt-Peterburg, 197758, Russia
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 3900)
RECRUITING

Warsaw, Masovian Voivodeship, 02-781, Poland

Contact Phone: •••-•••-••••
Northside Hospital-Northside Hospital Oncology Network ( Site 0156)
COMPLETED

Atlanta, Georgia, 30342, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0172)
COMPLETED

Omaha, Nebraska, 68130, United States
Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0179)
COMPLETED

Omaha, Nebraska, 68130, United States
Ospedale San Raffaele-Oncologia Medica ( Site 3303)
COMPLETED

Milan, 20132, Italy
Parkview Research Center at Parkview Regional Medical Center ( Site 0180)
COMPLETED

Fort Wayne, Indiana, 46845, United States
Princess Margaret Cancer Centre ( Site 3003)
COMPLETED

Toronto, Ontario, M5G 2M9, Canada
Rabin Medical Center-Oncology ( Site 3604)
RECRUITING

Petah Tikva, 4941492, Israel

Contact Phone: •••-•••-••••
Rambam Health Care Campus-Oncology ( Site 3600)
RECRUITING

Haifa, 3109601, Israel

Contact Phone: •••-•••-••••
Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 3702)
COMPLETED

Saint Petersburg, Leningradskaya Oblast', 198255, Russia
Samsung Medical Center ( Site 4100)
RECRUITING

Seoul, 06351, South Korea

Contact Phone: •••-•••-••••
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 3704)
COMPLETED

Saint Petersburg, 197758, Russia
Seoul National University Bundang Hospital-Medical Oncology ( Site 4104)
RECRUITING

Seongnam, Kyonggi-do, 13620, South Korea

Contact Phone: •••-•••-••••
Seoul National University Hospital ( Site 4101)
RECRUITING

Seoul, 03080, South Korea

Contact Phone: •••-•••-••••
Shaare Zedek Medical Center-Oncology ( Site 3602)
RECRUITING

Jerusalem, 9103102, Israel

Contact Phone: •••-•••-••••
Sheba Medical Center-ONCOLOGY ( Site 3603)
RECRUITING

Ramat Gan, 5265601, Israel

Contact Phone: •••-•••-••••
St Francis Cancer Center-Research Office ( Site 0167)
COMPLETED

Greenville, South Carolina, 29607, United States
St. Marys Hospital Center ( Site 3000)
COMPLETED

Montreal, Quebec, H3T 1M5, Canada
Standort Penzing der Klinik Ottakring-Abteilung für Atemwegs-und Lungenkrankheiten ( Site 3101)
RECRUITING

Vienna, 1140, Austria

Contact Phone: •••-•••-••••
The Prince Charles Hospital-Oncology Clinical Trials ( Site 4003)
COMPLETED

Brisbane, Queensland, 4032, Australia
UPMC Hillman Cancer Center ( Site 0177)
COMPLETED

Pittsburgh, Pennsylvania, 15232, United States
University of Kentucky Chandler Medical Center-Medical Oncology ( Site 0157)
COMPLETED

Lexington, Kentucky, 40536, United States
Virginia Cancer Institute ( Site 0169)
ACTIVE_NOT_RECRUITING

Richmond, Virginia, 23229, United States
Warminsko-Mazurskie Centrum Chorob Płuc w Olsztynie ( Site 3903)
COMPLETED

Olsztyn, Warmian-Masurian Voivodeship, 10-357, Poland
Westmead Hospital-Department of Medical Oncology ( Site 4004)
COMPLETED

Westmead, New South Wales, 2145, Australia
ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 3300)
RECRUITING

Siena, Tuscany, 53100, Italy

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

SMALL CELL LUNG CARCINOMA